Heart Matters

Since cardiovascular disease is one of the leading causes of death in the U.S., cardiology physicians are continuously working to better understand this common disease and to help patients improve their heart health. And here to assist cardiology physicians in this mission is Heart Matters, a series dedicated to covering essential strategies and research efforts focusing on all types of heart problems, including coronary artery diseases, heart attacks, high cholesterol, high blood pressure, and more.

So whether you’re looking for ways to improve heart health or catch up on the latest cardiology research, you never have to worry about missing a beat thanks to Heart Matters.

699

LikeLikedUnlike

LDL-C Management Trends in ASCVD Patients
Heart Matters
LDL-C Management Trends in ASCVD Patients
- Keith C. Ferdinand, MD, FACC, FAHA , FASPC, FNLA, FPCNA
  Peer
Bempedoic acid reduces adverse limb events in patients with PAD
Heart Matters
Bempedoic acid reduces adverse limb events in patients with PAD
- Marc Bonaca, MD
  Peer
No benefit of routine spironolactone post-MI
Heart Matters
No benefit of routine spironolactone post-MI
- Sanjit Jolly, MD
  Peer
Semaglutide reduces MACE in patients with obesity or overweight and prior CABG
Heart Matters
Semaglutide reduces MACE in patients with obesity or overweight and prior CABG
- Subodh Verma, MD, PhD
  Peer
Obicetrapib lowers LDL-c on top of other lipid-lowering therapies in HeFH
Heart Matters
Obicetrapib lowers LDL-c on top of other lipid-lowering therapies in HeFH
- Stephen Nicholls, FRACP, FACC, FESC, FAHA
  Peer
Promising results with oral Lp(a) inhibitor in phase 2 trial
Heart Matters
Promising results with oral Lp(a) inhibitor in phase 2 trial
- Stephen Nicholls, FRACP, FACC, FESC, FAHA
  Peer

Masterclass in Cardiac Amyloidosis: Disease Spectrum, Diagnosis, and Management
CME/CE
Masterclass in Cardiac Amyloidosis: Disease Spectrum, Diagnosis, and Management
- Saurabh Malhotra, MD, MPH
  Peer
- Kevin Alexander, MD
  Peer
- Tawfiq Al-lahham, MD
  Peer
- Sarah Cuddy, MD
  Peer
- Angela Dispenzieri, MD
  Peer
- Anita D’Souza, MD
  Peer
- Foluso Fakorede, MD
  Peer
- Mazen Hanna, MD
  Peer
- Isabelle Lousada
  Peer
- Ahmad Masri, MD, MS
  Peer
- Mathew S. Maurer, MD
  Peer
- Matthew Parker, MD
  Peer
- Frederick Ruberg, MD
  Peer
- Andrew Staron, MD
  Peer
- Prem Soman, MD, PhD
  Peer
- Jonathan Wall, PhD
  Peer
- Ashutosh Wechalekar, MBBS, MD
  Peer
- Panithaya Chareonthaitawee, MD
  Peer
Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)
CME/CE
Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)
- John Russell, MD
  Peer
- Noel Dasgupta, MD, FACC
  Peer
- Sami Khella, MD
  Peer
0.50 credits

Prioritizing LDL-C Reduction for Established CVD Patients in Primary Care
Medical Industry Feature
Prioritizing LDL-C Reduction for Established CVD Patients in Primary Care
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
  Peer
- Leah Cordovez, MD, FACP
  Peer
Confronting the Complexities of Reaching LDL-C Thresholds in Patients with Primary Hyperlipidemia
Medical Industry Feature
Confronting the Complexities of Reaching LDL-C Thresholds in Patients with Primary Hyperlipidemia
- Michael Bloch, MD
  Peer